Cargando…

In Vivo Safety of New Coating for Biodegradable Magnesium Implants

Biodegradable Magnesium (Mg) implants are promising alternatives to permanent metallic prosthesis. To improve the biocompatibility and with the aim of degradation control, we provided Plasma Electrolytic Oxidation (PEO) of pure Mg implant in silicate-based solution with NaOH (S1 250 V) and Ca(OH)(2)...

Descripción completa

Detalles Bibliográficos
Autores principales: Dryhval, Bohdan, Husak, Yevheniia, Sulaieva, Oksana, Deineka, Volodymyr, Pernakov, Mykola, Lyndin, Mykola, Romaniuk, Anatolii, Simka, Wojciech, Pogorielov, Maksym
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488394/
https://www.ncbi.nlm.nih.gov/pubmed/37687498
http://dx.doi.org/10.3390/ma16175807
_version_ 1785103464883290112
author Dryhval, Bohdan
Husak, Yevheniia
Sulaieva, Oksana
Deineka, Volodymyr
Pernakov, Mykola
Lyndin, Mykola
Romaniuk, Anatolii
Simka, Wojciech
Pogorielov, Maksym
author_facet Dryhval, Bohdan
Husak, Yevheniia
Sulaieva, Oksana
Deineka, Volodymyr
Pernakov, Mykola
Lyndin, Mykola
Romaniuk, Anatolii
Simka, Wojciech
Pogorielov, Maksym
author_sort Dryhval, Bohdan
collection PubMed
description Biodegradable Magnesium (Mg) implants are promising alternatives to permanent metallic prosthesis. To improve the biocompatibility and with the aim of degradation control, we provided Plasma Electrolytic Oxidation (PEO) of pure Mg implant in silicate-based solution with NaOH (S1 250 V) and Ca(OH)(2) (S2 300 V). Despite the well-structured surface, S1 250 V implants induced enormous innate immunity reaction with the prevalence of neutrophils (MPO+) and M1-macrophages (CD68+), causing secondary alteration and massive necrosis in the peri-implant area in a week. This reaction was also accompanied by systemic changes in visceral organs affecting animals’ survival after seven days of the experiment. In contrast, S2 300 V implantation was associated with focal lymphohistiocytic infiltration and granulation tissue formation, defining a more favorable outcome. This reaction was associated with the prevalence of M2-macrophages (CD163+) and high density of αSMA+ myofibroblasts, implying a resolution of inflammation and effective tissue repair at the site of the implantation. At 30 days, no remnants of S2 300 V implants were found, suggesting complete resorption with minor histological changes in peri-implant tissues. In conclusion, Ca(OH)(2)-contained silicate-based solution allows generating biocompatible coating reducing toxicity and immunogenicity with appropriate degradation properties that make it a promising candidate for medical applications.
format Online
Article
Text
id pubmed-10488394
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104883942023-09-09 In Vivo Safety of New Coating for Biodegradable Magnesium Implants Dryhval, Bohdan Husak, Yevheniia Sulaieva, Oksana Deineka, Volodymyr Pernakov, Mykola Lyndin, Mykola Romaniuk, Anatolii Simka, Wojciech Pogorielov, Maksym Materials (Basel) Article Biodegradable Magnesium (Mg) implants are promising alternatives to permanent metallic prosthesis. To improve the biocompatibility and with the aim of degradation control, we provided Plasma Electrolytic Oxidation (PEO) of pure Mg implant in silicate-based solution with NaOH (S1 250 V) and Ca(OH)(2) (S2 300 V). Despite the well-structured surface, S1 250 V implants induced enormous innate immunity reaction with the prevalence of neutrophils (MPO+) and M1-macrophages (CD68+), causing secondary alteration and massive necrosis in the peri-implant area in a week. This reaction was also accompanied by systemic changes in visceral organs affecting animals’ survival after seven days of the experiment. In contrast, S2 300 V implantation was associated with focal lymphohistiocytic infiltration and granulation tissue formation, defining a more favorable outcome. This reaction was associated with the prevalence of M2-macrophages (CD163+) and high density of αSMA+ myofibroblasts, implying a resolution of inflammation and effective tissue repair at the site of the implantation. At 30 days, no remnants of S2 300 V implants were found, suggesting complete resorption with minor histological changes in peri-implant tissues. In conclusion, Ca(OH)(2)-contained silicate-based solution allows generating biocompatible coating reducing toxicity and immunogenicity with appropriate degradation properties that make it a promising candidate for medical applications. MDPI 2023-08-24 /pmc/articles/PMC10488394/ /pubmed/37687498 http://dx.doi.org/10.3390/ma16175807 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Dryhval, Bohdan
Husak, Yevheniia
Sulaieva, Oksana
Deineka, Volodymyr
Pernakov, Mykola
Lyndin, Mykola
Romaniuk, Anatolii
Simka, Wojciech
Pogorielov, Maksym
In Vivo Safety of New Coating for Biodegradable Magnesium Implants
title In Vivo Safety of New Coating for Biodegradable Magnesium Implants
title_full In Vivo Safety of New Coating for Biodegradable Magnesium Implants
title_fullStr In Vivo Safety of New Coating for Biodegradable Magnesium Implants
title_full_unstemmed In Vivo Safety of New Coating for Biodegradable Magnesium Implants
title_short In Vivo Safety of New Coating for Biodegradable Magnesium Implants
title_sort in vivo safety of new coating for biodegradable magnesium implants
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488394/
https://www.ncbi.nlm.nih.gov/pubmed/37687498
http://dx.doi.org/10.3390/ma16175807
work_keys_str_mv AT dryhvalbohdan invivosafetyofnewcoatingforbiodegradablemagnesiumimplants
AT husakyevheniia invivosafetyofnewcoatingforbiodegradablemagnesiumimplants
AT sulaievaoksana invivosafetyofnewcoatingforbiodegradablemagnesiumimplants
AT deinekavolodymyr invivosafetyofnewcoatingforbiodegradablemagnesiumimplants
AT pernakovmykola invivosafetyofnewcoatingforbiodegradablemagnesiumimplants
AT lyndinmykola invivosafetyofnewcoatingforbiodegradablemagnesiumimplants
AT romaniukanatolii invivosafetyofnewcoatingforbiodegradablemagnesiumimplants
AT simkawojciech invivosafetyofnewcoatingforbiodegradablemagnesiumimplants
AT pogorielovmaksym invivosafetyofnewcoatingforbiodegradablemagnesiumimplants